The World Intellectual Property Organization will honor Cuban managers of anti-Covid-19 vaccines

Print
Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 
Rating:
( 0 Rating )

La Organización Mundial de la Propiedad Intelectual condecorará a gestores cubanos de vacunas antiCovid-19

The creators of the Cuban anti-Covid-19 vaccines Soberana 01, Soberana 02, Abdala and Mambisa will receive the Gold Medal for Inventors here on Monday, conferred by the World Intellectual Property Organization (WIPO).

The CEO of that United Nations organization, Daren Tang, who will be in Havana leading a delegation, will present the award. As revealed by the general director of the Cuban Office of Industrial Property, María de los Ángeles Sánchez, it is a recognition of scientists for their contributions to national economic and technological development.

The WIPO Gold Medal Program was established in 1979 with the purpose of stimulating innovative activity throughout the world, particularly in developing countries, and serves to attract and increase public recognition of inventors and their work. , according to the information on the agency's website.

To date, Cuba is worthy of a dozen of these awards for obtaining products such as the drug Heberprot-P, from the Center for Genetic Engineering and Biotechnology (CIGB), and the invention entitled Anti-CD6 monoclonal antibodies for the treatment and diagnosis of psoriasis, from the Center for Molecular Immunology.

The first of these was received in 1989 by the Finlay Vaccine Institute (IFV) for the immunogen against Meningococcus (Neisseria Meningitidis) of group B, and in 1999 Policosanol or PPG, a multiple-use drug, from the National Center for Scientific investigations, followed it.

In this case, the scientists who created the vaccines against SARS-CoV-2 are particularly recognized.

Soberana 01 and Soberana 02 were developed in Cuba by the IFV, while Abdala and Mambisa were conceived at the CIGB.